红日药业
(300026)
| 流通市值：100.54亿 | | | 总市值：100.64亿 |
| 流通股本：30.01亿 | | | 总股本：30.04亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 2,187,953,040.26 | 1,130,231,119.07 | 4,941,124,549.57 | 4,148,562,925.07 |
| 营业总成本 | 2,043,979,724.16 | 1,031,965,364.51 | 4,626,182,998.81 | 3,909,246,801.58 |
| 其他经营收益 | | | | |
| 营业利润 | 107,285,703.34 | 84,664,233.44 | 104,117,043.63 | 164,276,030.47 |
| 利润总额 | 107,436,797.17 | 84,273,769.22 | 82,646,078.39 | 141,200,123.42 |
| 净利润 | 82,910,766.17 | 68,620,267.67 | 22,223,495.61 | 91,928,688.51 |
| 每股收益 | | | | |
| 其他综合收益 | -7,015,750.94 | -3,980,233.43 | -55,625,918.77 | -308,935.97 |
| 综合收益总额 | 75,895,015.23 | 64,640,034.24 | -33,402,423.16 | 91,619,752.54 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 5,766,844,186.36 | 5,735,309,684.29 | 5,717,029,001.52 | 5,917,243,026.79 |
| 非流动资产: | | | | |
| 非流动资产合计 | 4,561,497,951.1 | 4,631,877,765.03 | 4,675,087,496.28 | 4,841,102,731.48 |
| 资产总计 | 10,328,342,137.46 | 10,367,187,449.32 | 10,392,116,497.8 | 10,758,345,758.27 |
| 流动负债: | | | | |
| 流动负债合计 | 1,319,301,088.6 | 1,220,249,884.71 | 1,281,652,619.81 | 1,387,512,698.83 |
| 非流动负债: | | | | |
| 非流动负债合计 | 325,907,558.62 | 426,759,766.66 | 456,147,336.3 | 575,271,952.73 |
| 负债合计 | 1,645,208,647.22 | 1,647,009,651.37 | 1,737,799,956.11 | 1,962,784,651.56 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 8,559,082,343.75 | 8,579,592,307.26 | 8,516,636,507.69 | 8,638,484,078.73 |
| 股东权益合计 | 8,683,133,490.24 | 8,720,177,797.95 | 8,654,316,541.69 | 8,795,561,106.71 |
| 负债和股东权益合计 | 10,328,342,137.46 | 10,367,187,449.32 | 10,392,116,497.8 | 10,758,345,758.27 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,688,305,712.87 | 1,295,291,826.7 | 5,817,254,892.03 | 4,601,234,883.42 |
| 经营活动现金流出小计 | 2,330,214,271.54 | 1,203,913,369.38 | 5,005,913,281.24 | 4,064,398,246.93 |
| 经营活动产生的现金流量净额 | 358,091,441.33 | 91,378,457.32 | 811,341,610.79 | 536,836,636.49 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 16,868,887.46 | 8,728.3 | 2,904,990.82 | 2,698,004.36 |
| 投资活动现金流出小计 | 47,954,718.65 | 28,836,828.69 | 130,249,796.03 | 96,062,756.25 |
| 投资活动产生的现金流量净额 | -31,085,831.19 | -28,828,100.39 | -127,344,805.21 | -93,364,751.89 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 83,429,052.02 | 794,748.89 | 55,331,629.05 | 51,259,969.06 |
| 筹资活动现金流出小计 | 255,046,097.42 | 32,417,549.7 | 525,343,943.06 | 381,018,304.05 |
| 筹资活动产生的现金流量净额 | -171,617,045.4 | -31,622,800.81 | -470,012,314.01 | -329,758,334.99 |
| 汇率变动对现金及现金等价物的影响 | -8,905,897.85 | -4,993,071.72 | -3,456,522.37 | -694,148.83 |
| 现金及现金等价物净增加额 | 146,482,666.89 | 25,934,484.4 | 210,527,969.2 | 113,019,400.78 |
| 期末现金及现金等价物余额 | 1,630,133,727.69 | 1,509,585,545.2 | 1,483,651,060.8 | 1,386,142,492.38 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 146,482,666.89 | - | 210,527,969.2 | - |